Roivant Sciences president and Immunovant CEO Eric Venker reports $7.62 million common share disposal

ROIV•2026-11-13

Eric Venker sold 187,943 common shares on Nov. 10, 2026, for about $7.62 million, in transactions at $40.44 and $41 per share. He retained direct ownership of 811,211 shares, a Form 4 dated Nov. 12 showed.

1. Share sale details

Venker sold 158,194 shares at $40.44 each and 29,749 shares at $41 each on Nov. 10. He retained direct ownership of 811,211 common shares, according to a Form 4 dated Nov. 12, 2026.

Sources

Roivant Sciences president and Immunovant CEO Eric Venker reports $7.62 million common share disposal

Sec

Roivant Sciences president and Immunovant CEO Eric Venker reports $7.62 million common share disposal

1. Share sale details

Related News

Big Digital Energy COO Cody Smith reports acquisition of $32,308.25 in common shares

Palvella Therapeutics Chief Scientific Officer Jeffrey S. Martini reports disposal of $2.08 million in common shares

PACS Group President and COO Joshua Jergensen reports sale of $2 million in common shares

Sources

Roivant Sciences president and Immunovant CEO Eric Venker reports $7.62 million common share disposal

Southern Company prices $1.75 billion equity unit offering

CBRE Investment Management sees ROAD Act boosting manufactured housing demand faster than lot supply